Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Candesartan cilexetil 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Ondansetron (as ondansetron hydrochloride) 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Cabergoline 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Methylprednisolone 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Hydromorphone hydrochloride 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Montelukast sodium 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely amitriptyline 10 milligram and perphenazine 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely amitriptyline 25 milligram and perphenazine 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely amitriptyline 50 milligram and perphenazine 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Product containing precisely carbinoxamine 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Perindopril erbumine 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Lacidipine 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Perphenazine 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Pimozide 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Risperidone 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely reboxetine 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Tizanidine (as tizanidine hydrochloride) 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
4 |
Triamcinolone 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Trandolapril 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Warfarin sodium 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Tiagabine hydrochloride 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Trichlormethiazide 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Product containing precisely ropinirole hydrochloride 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Lornoxicam 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Product containing precisely trandolapril 4 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Polythiazide 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely silodosin 4 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Iloperidone 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Pitavastatin 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Perampanel 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely pomalidomide 4 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Doxazosin (as doxazosin mesilate) 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Cyproheptadine hydrochloride 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Glimepiride 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Guanabenz acetate 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Dexamethasone 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Estradiol 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Indapamide 1.25 mg and perindopril erbumine 4 mg oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely amitriptyline 10 milligram and perphenazine 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
3 |
Product containing precisely amitriptyline 25 milligram and perphenazine 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Product containing precisely metformin hydrochloride 1 gram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Product containing precisely glycerol 4 gram/1 each conventional release rectal suppository (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely doxazosin (as doxazosin mesilate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Salbutamol (as salbutamol sulfate) 4 mg prolonged-release oral capsule |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Hydromorphone hydrochloride 4 mg prolonged-release oral capsule |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
4 |
Inferred relationship |
Some |
|
Product containing precisely chlorphenamine maleate 4 milligram and mepyramine maleate 25 milligram and phenylephrine hydrochloride 10 milligram and phenylpropanolamine 50 milligram/1 each conventional release oral tablet (clinical drug) |
Count of base of active ingredient |
False |
4 |
Inferred relationship |
Some |
|
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
Count of base of active ingredient |
False |
4 |
Inferred relationship |
Some |
|
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule |
Count of base of active ingredient |
False |
4 |
Inferred relationship |
Some |
|
Topotecan (as topotecan hydrochloride) 4 mg powder for solution for injection vial |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(rbe) 4 milligram/1 vial powder for conventional release solution for injection |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Sodium citrate 4 g granules for oral solution sachet |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
2 |
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Furosemide 4 mg/mL oral solution |
Has concentration strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Fluoxetine (as fluoxetine hydrochloride) 4 mg/mL oral solution |
Has concentration strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment |
Has concentration strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection ampule |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection ampule |
Has concentration strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely bumetanide 2 milligram/4 milliliter conventional release solution for injection ampule |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely dalteparin sodium 10000 unit/4 milliliter conventional release solution for injection ampule |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely bevacizumab 100 milligram/4 milliliter conventional release solution for injection vial |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely dalteparin sodium 100000 unit/4 milliliter conventional release solution for injection vial |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely desmopressin acetate 4 microgram/1 milliliter conventional release solution for injection ampule |
Has concentration strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely desmopressin acetate 4 microgram/1 milliliter conventional release solution for injection ampule |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/2 milliliter conventional release solution for injection ampule |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely mecasermin 40 milligram/4 milliliter conventional release solution for injection vial |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/4 milliliter conventional release solution for injection ampule |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely mesna 400 milligram/4 milliliter conventional release solution for injection ampule |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely pancuronium bromide 4 milligram/2 milliliter conventional release solution for injection ampule |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely sotalol hydrochloride 40 milligram/4 milliliter conventional release solution for injection ampule |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely testosterone undecanoate 1 gram/4 milliliter conventional release solution for injection ampule |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely nizatidine 100 milligram/4 milliliter conventional release solution for injection ampule |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely lorazepam 4 milligram/1 milliliter conventional release solution for injection ampule |
Has concentration strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely lorazepam 4 milligram/1 milliliter conventional release solution for injection ampule |
Has presentation strength numerator value |
False |
4 |
Inferred relationship |
Some |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 600 milligram/4 milliliter conventional release solution for injection ampule |
Has presentation strength denominator value |
False |
4 |
Inferred relationship |
Some |
1 |